In this paper, we propose a protocol for hybrid spheroid manufacturing using optical tweezers. This method allows precise control of the early stages of the spheroid formation process, which is unattainable by other methods.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
In this paper, we propose a protocol for hybrid spheroid manufacturing using optical tweezers. This method allows precise control of the early stages of the spheroid formation process, which is unattainable by other methods.
Two-dimensional (2D) cell culture is still among the most commonly used models in preclinical cancer research. However, the three-dimensional (3D) in vitro models appear to assess the in vivo environment more accurately, including a more relevant architectural morphology, microenvironment, and responses to drugs.
Optical trapping uses one or more focused laser beams to non-invasively manipulate the position, motion, interaction, and dynamics of structures on nano- and microscale. Optical tweezers (OT) have found numerous applications in cell biology; however, their potential in cancer research is still undervalued. In this paper, we recommend a noninvasive protocol for lymphoma-stromal cell spheroid formation with the use of optical tweezers. This method not only constructs the hybrid spheroids de novo but also enables controlling the number of attached cells and the time of adhesion formation, providing an important source of information for tissue engineering. Furthermore, OT enables the study of the early stages of hybrid spheroid formation, which cannot be achieved with standard bulk techniques. Importantly, the described model can be used to study the minimal changes in adhesion induced by anti-cancer drugs. This protocol can be easily applied to other cell types.
Three-dimensional (3D) cellular models are accelerating cancer research because they better resemble tumor tissue in several functional and structural properties. These include, among others, extracellular matrix production, interaction between cells, maintaining nutrient and oxygen gradients, and similar responses to the treatments1,2,3,4. Recently, to better reflect in vivo conditions, advanced heterogeneous 3D models involving various cell types have been developed5,6,7.
B-cell Non-Hodgkin Lymphoma (B-NHL) is a heterogeneous group of malignancies originating from B lymphocytes, integral components of the immune system8. Characterized by a diverse array of clinical presentations and histological features, B-NHL encompasses a spectrum of disorders, ranging from indolent forms with a protracted clinical course to aggressive variants that progress swiftly9,10. The pathogenesis of B-NHL and other hematological malignancies is often linked to the impact of the tumor microenvironment11,12. For instance, lymphoma cells often spread to the bone marrow, potentially resulting in life-threatening complications13. Mesenchymal stromal cells (MSCs), which are the key components of the bone marrow niche, have been recognized to impact tumor growth and progression14, largely through direct cell-cell interactions15,16,17; thus, there is an urgent need to develop models that allow studying such interplays. We previously established that MSCs, when co-cultured on agarose hydrogels with lymphoma cells, self-aggregate into multicellular spheroids, with stromal cells forming the core and being uniformly surrounded by lymphoma cells18. In this paper, we present a protocol for the fabrication of a hybrid lymphoma-stromal cells 3D model using optical tweezers.
Over 35 years ago, Ashkin first reported the phenomenon of non-invasive optical trapping of viruses and bacteria by focused laser beam19. Nowadays, optical tweezers (OT) have a dynamically increasing impact in the biomedical field, including cell biology research20,21,22,23. OT allowed studying not only the physico-mechanical properties of individual cell24,25,26but also the direct cell-cell interactions at a single cell level, and further 2D and 3D cellular arrangement and structuring27,28,29. The optical trapping technique is based on the optical forces of the order of a few piconewtons exerted as electromagnetic radiation (photons), which changes its momentum when it interacts with matter30. In consequence, by using one or more laser beams, operators may selectively manipulate positions, motion, and dynamics of objects in micro- and nanoscale20. In practice, the optical trapping technique allows for the selective and non-destructive trapping of living cells, placing them in contact with the surface of another cell or molecule and triggering the initiation of the adhesion process31. Using the above functionalities, we first attempted to optically place a single lymphoma cell onto a monolayer of stromal cells to investigate its adhesive properties. Next, we proceeded to assess the ability of optical tweezers to physically recreate a multicellular spheroid in real-time mode33. To achieve this, individual lymphoma cells were trapped one by one and attached to a previously prepared 3D stromal spheroid. Another applicability of optical trapping was to measure the minimum cell-cell adhesion time and assess the minute changes in adhesion resulting from the anti-cancer treatment34,35. Although 3D models are widely used in cancer research, studying the early stages of spheroid formation remains challenging. This is mainly due to the limited availability of methods that allow the micro-world to be touched with high precision and minimally invasive impact at the same time. Conversely, the full potential of OT is yet to be achieved within the scope of cellular arrangement and structure in 3D. Thus, in this paper, a combined workflow to generate 3D lymphoma construct using standard 3D techniques and manipulations in optical tweezers is described step by step. Importantly, the protocol may be easily adapted for use with other cell types of importance in hematopathological malignancies.
Access restricted. Please log in or start a trial to view this content.
1. Fabrication of agarose gel-based micromolds
NOTE: Proper aseptic techniques are essential when handling all cell cultures. All the reagents used in this protocol are listed in the Table of Materials. Prepare three gels with MSCs for a single experiment as shown in Figure 1A.

Figure 1: Preparation of mesenchymal stromal cell (MSC) spheroids. (A) Illustration depicting the step for preparing the agarose micromolds. (B) Seeding of mesenchymal stromal cells (MSCs), and cultivation of mesenchymal spheroids. Please click here to view a larger version of this figure.
2. Preparation of mesenchymal stromal cells (MSCs) spheroids
3. Culturing of lymphoma cells and preparation for optical trapping
NOTE: Hematological cell lines, including lymphoma cells, grow free-floating in the culture media in flasks designed for suspension culture without any attachment to the culture plate or vessel. To maintain optimal cell properties, it is recommended to start preparing the sample no earlier than 30 min before the procedure of assembling the hybrid spheroids using the optical tweezers. Importantly, the protocol outlined in this section is for the Ri-1 human lymphoma cell line, but a similar protocol applies to other hematological cancer cell lines.
4. Setting up the optical tweezers system
NOTE: The protocol below was developed specifically for the custom-built optical tweezers36 (Figure 2A). However, this assay can be used with other commercially available trapping systems. Regardless of what type of equipment is available, the basic steps for system preparation (e.g., starting the laser and computer software, mounting the sample, and testing the possibility of moving the cell in an optical trap), remain the same. All experiments were carried out at room temperature, i.e., 25 °C.

Figure 2: A schematic illustrating the working mechanism of hybrid spheroid generation by optical tweezers. (A) Custom-designed optical tweezers setup. (B) The process of attaching individual lymphoma cells to the surface of MSCs spheroid. A single lymphoma cell was optically trapped and attached to the surface of a stromal spheroid until a stable connection was formed. This process continued until the entire surface of the stromal spheroid was covered by lymphoma cells. (C) A representative image of immunohistochemical staining of the hybrid spheroid section was obtained using a monoclonal mouse anti-CD20 antibody against CD20. The immunostaining was performed using a monoclonal mouse anti-human antibody against CD20 on an autostainer (see Table of Materials), following the manufacturer's instructions. Please click here to view a larger version of this figure.
5. Generation of hybrid spheroids using optical tweezers
6. Determination of spheroid viability
Access restricted. Please log in or start a trial to view this content.
Our previous results showed that mesenchymal stromal cells cultured with lymphoma cells make up the homogenous stromal core to which cancer cells attach uniformly18. In this study, we have successfully engineered the human hybrid spheroid consisting of mesenchymal stromal cells and lymphoma cells using custom-built optical tweezers. Figure 2B shows a representative spheroid in a brightfield microscope, an essential part of the optical tweezers system. In turn,
Access restricted. Please log in or start a trial to view this content.
In this study, the hybrid spheroids of mesenchymal stromal core and lymphoma cells were engineered in real-time with the use of optical tweezers. New laser-based technologies, including trapping systems, are now commercially available and are becoming increasingly popular. However, to date, the majority of optical tweezers continue to be custom-built instruments; thus, calibration, operation procedures, and experimental geometries can vary between laboratories38,39
Access restricted. Please log in or start a trial to view this content.
The authors declare no conflicts of interest.
Authors sincere gratitude Nicholas Czarnik, whose careful editing significantly improved the clarity of the study.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| µ-Dish 35 mm, high glass bottom | IBIDI | 81158 | |
| 12-256 mico-mold 3D PetriDish | Microtissues Inc., RI, USA | 12-256TR | |
| 3 µm polystyrene microspheres | Polysciences | 17134-15 | |
| anti CD20 antibody (clone L26) | Dako | IS604 | |
| Automated Cell Counter, EVE | NanoEntek | EVE/ EVE-MC | |
| Autostainer Link 48 | Dako | D09634 | |
| Camera | Olympus | U-TV0.63XC | |
| CelCulture CO2 Incubator | Esco Technologies, Inc. | CCL | |
| Cell Counting Slides, EVE | NanoEntek | NE-EVS | |
| Cell line HS-5 | ATCC | CRL-3611 | |
| Cell line Ri-1 | DSMZ | ACC 585 | |
| Fetal Bovine Serum | Gibco | A5256701 | |
| Fluorescence microscope | Olympus | BX43 | |
| ImageJ program | National Institutes of Health, MD, USA | ||
| Inverted microscope | Olympus | IX73 | |
| Live/Dead reagent kit | Thermo Fisher Scientific | L3224 | |
| Penicillin-Streptomycin (10,000 U/mL) | Gibco | 15140122 | |
| Phosphate Buffered Saline, pH 7.4 | Gibco | 10010023 | |
| RPMI 1640 Medium | Gibco | 11875093 | |
| Sodium chloride solution | Sigma-Aldrich | 7647-14-5 | |
| Sodium Chloride solution 0.9 %, sterile | ITW ReITW Reagents, S.R.L.agents, S.R.L. | A1671 | |
| Trypan Blue Solution, 0.4% | Gibco | 15250061 | |
| TrypLE Express Enzyme (1X), no phenol red | Gibco | 12604013 | |
| Trypsin-EDTA (0.05%), phenol red | Gibco | 25300096 | |
| UltraPure Agarose | Invitrogen | 16500500 | |
| Optical tweezers setup | |||
| Dichroic mirrors | Thorlabs | DMSP805R | |
| Digital camera | Mikrotron GmbH | MC1362 | |
| Galvano-mirror XY scanning system | Thorlabs | GVS002 | |
| Inverted microscope | Olympus | IX71 | |
| Lens 1 | Thorlabs | AC254-050-B-ML | |
| Lens 2 | Thorlabs | AC508-200-B-ML | |
| Nd:YAG 1064 nm laser | Laser Quantum | Ventus |
Access restricted. Please log in or start a trial to view this content.